These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 8903210

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Fungal pneumonia in transplant recipients.
    Zeluff BJ.
    Semin Respir Infect; 1990 Mar; 5(1):80-9. PubMed ID: 2188321
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Future directions of antifungal chemotherapy.
    Graybill JR.
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S170-81. PubMed ID: 1562690
    [Abstract] [Full Text] [Related]

  • 46. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1997 Sep 12; 39(1009):86-8. PubMed ID: 9305292
    [No Abstract] [Full Text] [Related]

  • 47. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM.
    Am J Trop Med Hyg; 1996 Jul 12; 55(1):1-11. PubMed ID: 8702012
    [Abstract] [Full Text] [Related]

  • 48. [Chemotherapy of mycoses of the inner organs].
    Scholer HJ.
    Schweiz Med Wochenschr; 1968 Apr 20; 98(16):602-11. PubMed ID: 5688589
    [No Abstract] [Full Text] [Related]

  • 49. [Infections by Candida and cryptococci].
    Berenguer J, Blázquez R, Ocaña I, Lozano F.
    Enferm Infecc Microbiol Clin; 1998 Apr 20; 16 Suppl 1():29-35. PubMed ID: 9859617
    [Abstract] [Full Text] [Related]

  • 50. Fungal infections in the immunocompromised host.
    Hawkins C, Armstrong D.
    Clin Haematol; 1984 Oct 20; 13(3):599-630. PubMed ID: 6388935
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Fungal infections in children with malignant disease].
    Michel G.
    Arch Pediatr; 2011 May 20; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [Abstract] [Full Text] [Related]

  • 54. The growing problem of mycoses in patients infected with the human immunodeficiency virus.
    Diamond RD.
    Rev Infect Dis; 1991 May 20; 13(3):480-6. PubMed ID: 1866553
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
    Hostetler JS, Stevens DA.
    Med Klin (Munich); 1991 Dec 20; 86 Suppl 1():8-10. PubMed ID: 1663205
    [Abstract] [Full Text] [Related]

  • 57. The challenge of invasive fungal infection.
    de Pauw BE, Meunier F.
    Chemotherapy; 1999 Jun 20; 45 Suppl 1():1-14. PubMed ID: 10394016
    [Abstract] [Full Text] [Related]

  • 58. Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis.
    Bonifaz A, Vázquez-González D, Perusquía-Ortiz AM.
    J Dtsch Dermatol Ges; 2011 Sep 20; 9(9):705-14; quiz 715. PubMed ID: 21722309
    [Abstract] [Full Text] [Related]

  • 59. In vivo models: evaluating antifungal agents.
    Dixon DM.
    Methods Find Exp Clin Pharmacol; 1987 Nov 20; 9(11):729-38. PubMed ID: 3448452
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.